Emicizumab-kxwh Subcutaneous and Pneumococcal Conjugate Vaccine (7-Valent)
Determining the interaction of Emicizumab-kxwh Subcutaneous and Pneumococcal Conjugate Vaccine (7-Valent) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: pneumococcal 7-valent vaccine
Brand name: Prevnar
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Emicizumab-kxwh Subcutaneous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Emicizumab-kxwh Subcutaneous-Pneumovax 23
- Emicizumab-kxwh Subcutaneous-PNV - Omega
- Emicizumab-kxwh Subcutaneous-PNV Iron Polysaccharides, Folic Acid, DHA
- Emicizumab-kxwh Subcutaneous-PNV OB with DHA
- Pneumococcal Conjugate Vaccine (7-Valent)-Emla
- Pneumococcal Conjugate Vaccine (7-Valent)-Emla Topical
- Pneumococcal Conjugate Vaccine (7-Valent)-Emo-Cort Scalp Solution Topical application
- Pneumococcal Conjugate Vaccine (7-Valent)-Emo-Cort Topical application
- Pneumococcal Conjugate Vaccine (7-Valent)-Emoquette
- Pneumococcal Conjugate Vaccine (7-Valent)-Empagliflozin